Decision Support Unit | ||||||
4 — th Floor AMP Place, 10 Eagle St Brisbane | 2 — nd Floor Blackburn House, 199 Grenfell St Adelaide | |||||
SOP Bulletin No. 38 | ||||||
17 July, 2000
Myelodysplastic disorder | |
Malignant neoplasm of the bile duct Chloracne | |
Nil |
IMPORTANT OPERATIONAL FEATURES
Myelodysplastic disorder |
- This SOP covers an uncommon group of disorders of blood cell production (the refractory anaemias).
- It includes a new style benzene factor and definition, without a requirement for occupational exposure. The RMA wants to avoid factors with such a requirement, as it is the level of exposure, not the setting, that is important.
- The only other causal factor is for certain chemotherapy drugs.
Malignant neoplasm of the bile duct | Revocation – 17 & 18 of '00 Replaces 34 and 35 of '99 |
- Cirrhosis of the liver has been added as a causal factor.
- The only other changes are to include ICD 10 codes and delete the definition of ulcerative colitis.
Chloracne | Revocation – 19 & 20 of '00 Replaces 69 and 70 of '94 And 279 and 280 of '95 |
- The “being exposed to herbicides in Vietnam” factor has been removed, in keeping with the RMA's objective of avoiding SOP factors that relate to classes of veterans.
- The factor is effectively replaced by one requiring exposure to any of a specific group of chemicals, in any setting or location. CCPS commentary will provide advice on circumstances in which exposure to these chemicals could occur.
Contact Officers for this bulletin: |
Maureen Anderson — 08 8290 0365 Dr Bev Grehan — 07 3223 8376 Dr Jon Kelley — 07 3223 8412 |
Remember! If you are having any problems with SOPs, or SOPs in CCPS, talk to us!